TABLE 5.
Evaluation of hippocampal atrophy and parietal lobe atrophy [n (%)].
| NC (N = 20) | MCI (N = 21) | AD (N = 20)*# | H | p | ||
| MTA score | Grade 0 | 16 (80) | 7 (33.3) | 0 (0) | 35.885 | <0.001 |
| Grade 1 | 2 (10) | 9 (42.9) | 1 (5) | |||
| Grade 2 | 2 (10) | 5 (23.8) | 14 (70) | |||
| Grade 3 | 0 (0) | 0 (0) | 5 (25) | |||
| Koedam score | Grade 0 | 14 (70) | 6 (28.6) | 4 (20) | 15.537 | <0.001 |
| Grade 1 | 6 (30) | 15 (71.4) | 9 (45) | |||
| Grade 2 | 0 (0) | 0 (0) | 7 (35) |
NC, normal cognition; MCI, mild cognitive impairment; AD, Alzheimer’s disease, MTA, medial temporal lobe atrophy. *p < 0.05 vs. NC group in MTA score and Koedam score; #p < 0.05 vs. MCI group in MTA score.